Literature DB >> 9821858

Functional role of chymase in angiotensin II formation in human vascular tissue.

S Takai1, N Shiota, D Jin, M Miyazaki.   

Abstract

Recent reports suggested that human heart chymase contributed little to angiotensin (Ang) II formation in the presence of natural protease inhibitors such as alpha-antitrypsin. We studied whether chymase could contribute to Ang II formation in the presence of natural protease inhibitors in the homogenate, the extract, and slices of human vascular tissue, and whether these inhibitors affect Ang I-induced vasocontractile responses due to chymase. In the homogenate, lisinopril, chymostatin, and alpha-antitrypsin inhibited the formation of Ang II by 14, 92, and 74%, respectively. In the extract, the inhibition of Ang II formation by lisinopril, chymostatin, and alpha-antitrypsin was 18, 94, and 93%, respectively. In the slices, lisinopril and chymostatin inhibited Ang II formation by 5 and 90%, respectively. However, unlike the homogenate and the extract experiments, only 8% of the Ang II formation was suppressed by alpha-antitrypsin. In isolated human gastroepiploic artery, 30% of Ang I-induced vasoconstriction was blocked by lisinopril, and the rest was completely eliminated by a combination of lisinopril and chymostatin. On the other hand, alpha-antitrypsin was ineffective in blocking Ang I-induced vasoconstriction in the presence of lisinopril, which demonstrates that Ang II formation is dependent on chymase. These findings suggest that chymase in human vascular tissue plays a functional role in Ang II formation in the presence of natural protease inhibitors such as alpha-antitrypsin.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9821858     DOI: 10.1097/00005344-199811000-00020

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  7 in total

1.  Possible roles of mast cell-derived chymase for skin rejuvenation.

Authors:  Nobuyuki Amano; Shinji Takai; Denan Jin; Koichi Ueda; Mizuo Miyazaki
Journal:  Lasers Med Sci       Date:  2008-04-12       Impact factor: 3.161

2.  Expression and activity levels of chymase in mast cells of burn wound tissues increase during the healing process in a hamster model.

Authors:  Xianglin Dong; Tao Xu; Shaolin Ma; Hao Wen
Journal:  Exp Ther Med       Date:  2015-04-14       Impact factor: 2.447

3.  Impact of Mast Cell Chymase on Renal Disease Progression.

Authors:  Haimanot Wasse; Nawazish Naqvi; Ahsan Husain
Journal:  Curr Hypertens Rev       Date:  2012-02-01

Review 4.  Angiotensin-converting enzyme inhibitors.

Authors:  Joseph L Izzo; Matthew R Weir
Journal:  J Clin Hypertens (Greenwich)       Date:  2011-07-18       Impact factor: 3.738

5.  Effectiveness and safety of valsartan in children aged 6 to 16 years with hypertension.

Authors:  Thomas Wells; Jeffrey Blumer; Kevin E C Meyers; Jose P R Neto; Rejane Meneses; Mieczysław Litwin; Johan Vande Walle; Susan Solar-Yohay; Victor Shi; Guangyang Han
Journal:  J Clin Hypertens (Greenwich)       Date:  2011-03-18       Impact factor: 3.738

6.  A Chymase Inhibitory RNA Aptamer Improves Cardiac Function and Survival after Myocardial Infarction.

Authors:  Denan Jin; Shinji Takai; Yosuke Nonaka; Satoko Yamazaki; Masatoshi Fujiwara; Yoshikazu Nakamura
Journal:  Mol Ther Nucleic Acids       Date:  2018-11-13

7.  Mast cells: pivotal players in cardiovascular diseases.

Authors:  Ilze Bot; Theo J C van Berkel; Erik A L Biessen
Journal:  Curr Cardiol Rev       Date:  2008-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.